Literature DB >> 24958816

Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.

Maulik Patel1, Takeharu Kawano1, Nobuchika Suzuki1, Takao Hamakubo1, Andrei V Karginov1, Tohru Kozasa2.   

Abstract

Gastrin-releasing peptide receptor (GRPR) is ectopically expressed in over 60% of colon cancers. GRPR expression has been correlated with increased colon cancer cell migration. However, the signaling pathway by which GRPR activation leads to increased cancer cell migration is not well understood. We set out to molecularly dissect the GRPR signaling pathways that control colon cancer cell migration through regulation of small GTPase RhoA. Our results show that GRP stimulation activates RhoA predominantly through G13 heterotrimeric G-protein signaling. We also demonstrate that postsynaptic density 95/disk-large/ZO-1 (PDZ)-RhoGEF (PRG), a member of regulator of G-protein signaling (RGS)-homology domain (RH) containing guanine nucleotide exchange factors (RH-RhoGEFs), is the predominant activator of RhoA downstream of GRPR. We found that PRG is required for GRP-stimulated colon cancer cell migration, through activation of RhoA-Rho-associated kinase (ROCK) signaling axis. In addition, PRG-RhoA-ROCK pathway also contributes to cyclo-oxygenase isoform 2 (Cox-2) expression. Increased Cox-2 expression is correlated with increased production of prostaglandin-E2 (PGE2), and Cox-2-PGE2 signaling contributes to total GRPR-mediated cancer cell migration. Our analysis reveals that PRG is overexpressed in colon cancer cell lines. Overall, our results have uncovered a key mechanism for GRPR-regulated colon cancer cell migration through the Gα13-PRG-RhoA-ROCK pathway.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24958816      PMCID: PMC4576495          DOI: 10.1124/mol.114.093914

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  63 in total

1.  Determination of GTP loading on Rho.

Authors:  X D Ren; M A Schwartz
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  RGS3 is a GTPase-activating protein for g(ialpha) and g(qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g(qalpha) and g(11alpha).

Authors:  A Scheschonka; C W Dessauer; S Sinnarajah; P Chidiac; C S Shi; J H Kehrl
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

3.  Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links heterotrimeric G proteins of the G(12) family to Rho.

Authors:  S Fukuhara; H Chikumi; J S Gutkind
Journal:  FEBS Lett       Date:  2000-11-24       Impact factor: 4.124

4.  Characterization of gastrin-releasing peptide and its receptor aberrantly expressed by human colon cancer cell lines.

Authors:  R E Carroll; D Ostrovskiy; S Lee; A Danilkovich; R V Benya
Journal:  Mol Pharmacol       Date:  2000-09       Impact factor: 4.436

5.  ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc.

Authors:  C Zhang; S Zhang; Z Zhang; J He; Y Xu; S Liu
Journal:  Oncogene       Date:  2013-12-09       Impact factor: 9.867

6.  Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2.

Authors:  C V Carman; J L Parent; P W Day; A N Pronin; P M Sternweis; P B Wedegaertner; A G Gilman; J L Benovic; T Kozasa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.

Authors:  A V Somlyo; D Bradshaw; S Ramos; C Murphy; C E Myers; A P Somlyo
Journal:  Biochem Biophys Res Commun       Date:  2000-03-24       Impact factor: 3.575

8.  Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.

Authors:  Xun Shang; Fillipo Marchioni; Chris R Evelyn; Nisha Sipes; Xuan Zhou; William Seibel; Matthew Wortman; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.

Authors:  Amanda P Struckhoff; Manish K Rana; Swapnil S Kher; Matt E Burow; Joseph L Hagan; Luis Del Valle; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

10.  LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.

Authors:  Susan M W Harrison; Teresa Knifley; Min Chen; Kathleen L O'Connor
Journal:  BMC Cancer       Date:  2013-10-27       Impact factor: 4.430

View more
  16 in total

1.  ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice.

Authors:  David I Kasahara; Joel A Mathews; Chan Y Park; Youngji Cho; Gabrielle Hunt; Allison P Wurmbrand; James K Liao; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-14       Impact factor: 5.464

Review 2.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 3.  Bombesin receptor subtype 3 as a potential target for obesity and diabetes.

Authors:  Nieves González; Paola Moreno; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2015-06-12       Impact factor: 6.902

4.  Lifetime of muscarinic receptor-G-protein complexes determines coupling efficiency and G-protein subtype selectivity.

Authors:  Olga S Ilyaskina; Horst Lemoine; Moritz Bünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

Review 5.  RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.

Authors:  Qianyi Lu; Li Lu; Wei Chen; Haibing Chen; Xun Xu; Zhi Zheng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

Review 6.  Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.

Authors:  Anna Bagnato; Laura Rosanò
Journal:  Small GTPases       Date:  2016-10-03

7.  Leukemia-Associated Rho Guanine Nucleotide Exchange Factor and Ras Homolog Family Member C Play a Role in Glioblastoma Cell Invasion and Resistance.

Authors:  Zonghui Ding; Zhiwan Dong; Yuping Yang; Shannon P Fortin Ensign; Hemragul Sabit; Mitsutoshi Nakada; Rosamaria Ruggieri; Jean M Kloss; Marc Symons; Nhan L Tran; Joseph C Loftus
Journal:  Am J Pathol       Date:  2020-07-18       Impact factor: 4.307

8.  Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.

Authors:  Said M Elshafae; Bardes B Hassan; Wachiraphan Supsavhad; Wessel P Dirksen; Rachael Y Camiener; Haiming Ding; Michael F Tweedle; Thomas J Rosol
Journal:  Prostate       Date:  2016-03-04       Impact factor: 4.104

9.  Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.

Authors:  E Semprucci; P Tocci; R Cianfrocca; R Sestito; V Caprara; M Veglione; V Di Castro; F Spadaro; G Ferrandina; A Bagnato; L Rosanò
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

10.  Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.

Authors:  Ji Hee Ha; Rohini Gomathinayagam; Mingda Yan; Muralidharan Jayaraman; Rajagopal Ramesh; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.